89 related articles for article (PubMed ID: 7250073)
1. The effect of nomifensine on prolactin secretion in patients with suspected pituitary microadenoma.
Jeske W; Stopińska U
Endokrynol Pol; 1981; 32(1):17-24. PubMed ID: 7250073
[No Abstract] [Full Text] [Related]
2. Nomifensine: diagnostic test in hyperprolactinemic states.
Müller EE; Genazzani AR; Murru S
J Clin Endocrinol Metab; 1978 Dec; 47(6):1352-7. PubMed ID: 263356
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
[TBL] [Abstract][Full Text] [Related]
4. Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.
Ferrari C; Crosignani PG; Caldara R; Picciotti MC; Malinverni A; Barattini B; Rampini P; Telloli P
J Clin Endocrinol Metab; 1980 Jan; 50(1):23-6. PubMed ID: 7188615
[TBL] [Abstract][Full Text] [Related]
5. Approach to the diagnosis of hyperprolactinemic states: the nomifensine and domperidone tests.
Molinatti GM; Camanni F; Cocchi D; De Leo V; Genazzni AR; Massara F; Muller EE
Panminerva Med; 1981; 23(1):5-10. PubMed ID: 7290727
[No Abstract] [Full Text] [Related]
6. [Indirect dopamine agonists and direct dopamine antagonists in the diagnosis of hyperprolactinemia].
De Leo V; Massafra C; La Marca S; De Leo M; Venturi C; Urbani TM; Genazzani AR
Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1025-31. PubMed ID: 7138672
[TBL] [Abstract][Full Text] [Related]
7. Some critical considerations on the use of the nomifensine test in the hyperprolactinaemic syndrome.
D'Agata R; Aliffi A; Vicari E; Volpicelli D; Mongioì A; Gulizia S
Horm Res; 1981; 14(3):148-54. PubMed ID: 7286887
[TBL] [Abstract][Full Text] [Related]
8. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE
Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
[TBL] [Abstract][Full Text] [Related]
9. Nomifensine in the diagnosis of hyperprolactinemia.
Gullo D; Carmina E; Mogavero G; Perino A; Venezia R
Acta Eur Fertil; 1981 Dec; 12(4):299-306. PubMed ID: 7342611
[TBL] [Abstract][Full Text] [Related]
10. [Progress in the hormonal detection of pituitary prolactin adenoma].
De Gennes JL; Turpin G; Heshmati HM; Carayon A
Ann Med Interne (Paris); 1982; 133(1):12-6. PubMed ID: 7065584
[No Abstract] [Full Text] [Related]
11. Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas.
Pontiroli AE; Loda G; Roggia A; Scagliola P; Falsetti L
Acta Endocrinol (Copenh); 1982 Oct; 101(2):171-9. PubMed ID: 7136447
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
Moriondo P; Travaglini P; Nissim M; Faglia G
Clin Endocrinol (Oxf); 1980 Dec; 13(6):525-33. PubMed ID: 7226570
[TBL] [Abstract][Full Text] [Related]
13. Agreement of prolactin response to cimetidine and nomifensine in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.
Iodice M; Lombardi G; Tommaselli A; Rossi R; Annunziato L; Minozzi M
Neuroendocrinology; 1982 Nov; 35(5):333-5. PubMed ID: 7145025
[No Abstract] [Full Text] [Related]
14. Nomifensine-induced pregnancy in a hyperprolactinemic woman.
Genazzani AR; De Leo V; Camanni F; Müller EE
J Endocrinol Invest; 1982; 5(2):129-30. PubMed ID: 7096920
[No Abstract] [Full Text] [Related]
15. Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology.
Camanni F; Genazzani AR; Massara F; de Leo V; Molinatti GM; Müller EE
J Clin Endocrinol Metab; 1980 Sep; 51(3):650-3. PubMed ID: 7410539
[No Abstract] [Full Text] [Related]
16. Biochemical diagnosis of prolactinoma.
Müller EE; Genazzani A; Camanni F; Massara F; Molinatti GM; Cocchi D
Lancet; 1979 Aug; 2(8136):257. PubMed ID: 89375
[No Abstract] [Full Text] [Related]
17. Effect of two indirectly acting dopamine agonists on prolactin secretion in normo- and hyperprolactinemic subjects: comparison with the effect of nomifensine.
Camanni F; Genazzani AR; de Leo V; Molinatti GM; Campagnoli C; Cocchi D; Müller EE
Neuroendocrinology; 1981 Nov; 33(5):300-5. PubMed ID: 7301051
[No Abstract] [Full Text] [Related]
18. [The metoclopramide and nomifensine tests in the diagnosis of prolactinomas].
Aguirre Sánchez-Covisa M; Ruiz-Valdepeñas MP; Larrodera L; Jaunsolo MA; Hawkins FG
Rev Clin Esp; 1986 Mar; 178(4):172-6. PubMed ID: 3715120
[No Abstract] [Full Text] [Related]
19. Prolactin production by pituitary adenomas.
Horvath E; Kovacs K; Ezrin C
JAMA; 1976 Oct; 236(15):1692-3. PubMed ID: 989507
[No Abstract] [Full Text] [Related]
20. [Prolactin-secreting pituitary gland adenoma. Present-day possibilities of diagnosis and treatment].
Basso A; Guitelman A; Amezua L; Molocznik I; Mancini A; Montez M
Neurochirurgie; 1975; 21(2):111-20. PubMed ID: 1105224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
